US-based PerkinElmer acquires Tulip Diagnostics

PerkinElmer Inc, the US-based company that provides analytical & lab equipment & services in areas of human and environmental health, has acquired has entered into a definitive agreement to acquire Tulip Diagnostics Pvt Ltd. 

Based in Goa, Tulip is one of the country’s largest domestic providers of in-vitro diagnostic reagents, kits and instruments to an expansive customer base of diagnostic labs and government and private healthcare facilities. Tulip's solutions include products for the prevention, screening and diagnosis of infectious diseases such as malaria, HIV and hepatitis. 

"As we continue to build out our diagnostics business on a global scale, this acquisition further positions PerkinElmer for long-term growth in emerging market diagnostics, an attractive end market and key area of focus for us. We are committed to expanding our infectious disease screening menu and capabilities, and Tulip's product portfolio, channel access, and broad footprint provide the key enablers to help accelerate our growth in this important market,” said Prahlad Singh, senior vice president and president, diagnostics, PerkinElmer.